Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
Netherlands
/
Materials
/
DSM-Firmenich
Create a narrative
DSM-Firmenich Community
ENXTAM:DSFIR Community
3
Narratives
written by author
0
Comments
on narratives written by author
32
Fair Values set
on narratives written by author
Community Investing Ideas
DSM-Firmenich
Popular
Undervalued
Overvalued
DSM-Firmenich
AN
AnalystLowTarget
Consensus Narrative from 20 Analysts
Regulatory And Merger Challenges Will Constrain Benefits But Spark Growth
Key Takeaways Increased regulatory pressures and supply chain complexities risk offsetting operational gains, potentially limiting margin expansion and profit growth despite sustainability-driven demand. Integration challenges, disruptive technologies, and intensified competition may cap revenue growth and undermine margins, even with ongoing innovation and higher-margin portfolio focus.
View narrative
€87.59
FV
4.2% undervalued
intrinsic discount
1.23%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
5 days ago
author updated this narrative
DSM-Firmenich
AN
AnalystHighTarget
Consensus Narrative from 20 Analysts
Sustainability And Precision Nutrition Will Fuel Global Market Expansion
Key Takeaways Accelerated synergy realization and strategic divestitures are enhancing margins, unlocking capital, and positioning for faster, higher-quality earnings growth. Strong focus on sustainable, innovative solutions and local customer-driven expansion is driving above-market growth and expanding margins across global and emerging markets.
View narrative
€146.00
FV
42.5% undervalued
intrinsic discount
4.67%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
5 days ago
author updated this narrative
DSM-Firmenich
AN
AnalystConsensusTarget
Consensus Narrative from 20 Analysts
Health And Bio-Based Trends Will Drive Future Success
Key Takeaways Focus on health-driven innovations, sustainability, and bio-based solutions enhances product differentiation, pricing power, and positions DSM-Firmenich for sustained organic growth. Integration synergies and increased exposure to local and regional customers boost margin improvements and revenue stability amid tightening sustainability regulations.
View narrative
€117.75
FV
28.8% undervalued
intrinsic discount
2.93%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
17
users have followed this narrative
5 days ago
author updated this narrative
Your Valuation for
DSFIR
DSFIR
DSM-Firmenich
Your Fair Value
€
Current Price
€83.88
12.3% overvalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-254m
15b
2015
2018
2021
2024
2025
2027
2030
Revenue €15.2b
Earnings €838.9m
Advanced
Set Fair Value